---
id: hhv8-kshv_296
category: organisms
tags: [HHV-8, KSHV, kaposi-sarcoma, primary-effusion-lymphoma, castleman-disease, HIV, oncogenic-virus]
deck: Infectious Diseases
created: 2025-01-11
modified: 2025-01-11
---

## Kaposi Sarcoma–Associated Herpesvirus (HHV-8/KSHV)

**Q:** What are the associated diseases, epidemiology, and management of HHV-8/KSHV infection?

**A:**

**Associated Diseases:**

| Disease | Clinical Features | Population at Risk |
|---------|-------------------|--------------------|
| **Kaposi Sarcoma (KS)** | Vascular tumors (skin, mucosa, viscera); 4 forms: epidemic (AIDS), classic (elderly Mediterranean), endemic (African), iatrogenic (transplant) | **AIDS-related KS** most common (90% are HHV-8+) |
| **Primary Effusion Lymphoma (PEL)** | Body cavity B-cell lymphoma (pleural, pericardial, peritoneal) **without solid tumor mass** | AIDS patients (CD4 <50) |
| **Multicentric Castleman Disease (MCD)** | Systemic inflammatory syndrome: fever, lymphadenopathy, splenomegaly, cytopenias | HIV+ > HIV- |

**Epidemiology:**

- **Seroprevalence**: 3-7% (general US), **20-30% (MSM)**, >50% (sub-Saharan Africa)
- **Transmission**: Saliva (primary), sexual contact, vertical transmission (rare)
- **HIV connection**: KS was AIDS-defining illness pre-ART; **90% reduction in KS incidence** with ART

**Management:**

**AIDS-Related Kaposi Sarcoma:**
- **Primary therapy**: **ART** (immune reconstitution → tumor regression in most)
- Indications for chemotherapy:
  - **Visceral KS** (GI, pulmonary) → **liposomal doxorubicin** or paclitaxel
  - Rapid progression or extensive cutaneous disease
- Local therapy: cryotherapy, radiation for limited lesions

**Primary Effusion Lymphoma/MCD:**
- ART + chemotherapy (CHOP-based regimens)
- **Rituximab + chemotherapy** for MCD
- Anti-IL-6 therapy (siltuximab) for MCD

**Pearl:** AIDS-related KS responds to ART alone in most cases; visceral involvement requires chemotherapy. HHV-8 is the ONLY virus causally associated with Kaposi sarcoma.

**Media:**

**Sources:** [PMC7281784 - KSHV/HHV-8 Comprehensive Review], [NCI Kaposi Sarcoma Treatment], [NCCN AIDS-Related Kaposi Sarcoma Guidelines], [Lancet ID HHV-8 Review 2024]
